The 2019 Annual Report of Bayer AG states: Interests in subsidiaries, joint ventures and associates that do not have a material impact on the Group’s financial position or results of operations, either individually or in aggregate, are not consolidated but recognized as financial investments in equity instruments. Discuss what criteria might have applied in determining that a subsidiary does not have a material impact.